Chronic Lymphocytic Leukemia

Showing NaN - NaN of 30

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Adult Chronic Lymphocytic Leukemia Receiving Oral Venetoclax

Recruiting
  • Chronic Lymphocytic Leukemia
    • London, London, City Of, United Kingdom
    • +9 more
    Jan 13, 2023

    Chronic Lymphocytic Leukemia Trial in Poland, United Kingdom (Ceralasertib, Acalabrutinib)

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • Kraków, Poland
    • +10 more
    Dec 2, 2022

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Richter's Syndrome Trial in Italy, United Kingdom, United States

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • +3 more
    • Boston, Massachusetts
    • +11 more
    Nov 23, 2022

    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Canada, United States (biological, other, drug)

    Recruiting
    • Chronic Lymphocytic Leukemia
    • Small Lymphocytic Lymphoma
    • Obinutuzumab
    • +3 more
    • Birmingham, Alabama
    • +484 more
    Aug 24, 2022

    Relapsed/Refractory B Cell Malignancies, Mantle Cell Lymphoma and Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia

    Active, not recruiting
    • Relapsed/Refractory B Cell Malignancies
    • +3 more
    • Columbus, Ohio
    • +17 more
    Aug 18, 2022

    Chronic Lymphocytic Leukemia Trial in Worldwide (Obinutuzumab, Ublituximab, TGR-1202)

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
    • Obinutuzumab
    • +3 more
    • Huntsville, Alabama
    • +153 more
    Aug 19, 2022

    Economic Analysis of Alliance A041202 CLL Study

    Active, not recruiting
    • Chronic Lymphocytic Leukemia
      • Calgary, Alberta, Canada
      • +14 more
      Jun 13, 2022

      Chronic Lymphocytic Leukemia Trial in Worldwide (Acalabrutinib (ACP-196), Rituximab, Idelalisib)

      Active, not recruiting
      • Chronic Lymphocytic Leukemia
      • Acalabrutinib (ACP-196)
      • +3 more
      • Chandler, Arizona
      • +156 more
      Jun 2, 2022

      Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma Trial in Worldwide (Ibrutinib)

      Enrolling by invitation
      • Chronic Lymphocytic Leukemia
      • +6 more
      • Duarte, California
      • +165 more
      Mar 24, 2022

      Chronic Lymphocytic Leukemia, 17p Deletion, Cancer of the Blood and Bone Marrow Trial in Worldwide (ABT-199 (Main Cohort),

      Completed
      • Chronic Lymphocytic Leukemia
      • +2 more
      • ABT-199 (Main Cohort)
      • ABT-199 (Safety Expansion Cohort)
      • Tucson, Arizona
      • +47 more
      Nov 19, 2021

      Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Zanubrutinib, Ibrutinib)

      Active, not recruiting
      • Chronic Lymphocytic Leukemia
      • Small Lymphocytic Lymphoma
      • Little Rock, Arkansas
      • +144 more
      Dec 3, 2021

      Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Post-Chlorambucil Therapy Follow-up, Ibrutinib,

      Active, not recruiting
      • Chronic Lymphocytic Leukemia
      • Small Lymphocytic Lymphoma
      • Post-Chlorambucil Therapy Follow-up
      • +4 more
      • Duarte, California
      • +106 more
      Aug 6, 2021

      Chronic Lymphocytic Leukemia, Small-Cell Lymphoma Trial in Worldwide (Ibrutinib, Obinutuzumab, Chlorambucil)

      Completed
      • Chronic Lymphocytic Leukemia
      • Small-Cell Lymphoma
      • La Jolla, California
      • +70 more
      Aug 27, 2020

      Chronic Lymphocytic Leukemia Trial in Worldwide (Idelalisib, Rituximab, Bendamustine)

      Completed
      • Chronic Lymphocytic Leukemia
      • Huntsville, Alabama
      • +105 more
      Mar 2, 2020

      Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Ibrutinib, Bendamustine HCl, Rituximab)

      Completed
      • Chronic Lymphocytic Leukemia
      • Small Lymphocytic Lymphoma
      • Birmingham, Alabama
      • +159 more
      Feb 20, 2020

      Chronic Lymphocytic Leukemia, Leukemia, B-Cell, Chronic Trial in Worldwide (lenalidomide)

      Completed
      • Chronic Lymphocytic Leukemia
      • Leukemia, B-Cell, Chronic
      • Tucson, Arizona
      • +34 more
      Nov 6, 2019

      Chronic Lymphocytic Leukemia Trial in Worldwide (Idelalisib)

      Terminated
      • Chronic Lymphocytic Leukemia
      • Huntsville, Alabama
      • +44 more
      Aug 12, 2019

      Chronic Lymphocytic Leukemia Trial in Worldwide (Idelalisib, Ofatumumab)

      Terminated
      • Chronic Lymphocytic Leukemia
      • Duarte, California
      • +79 more
      Aug 5, 2019

      Chronic Lymphocytic Leukemia Trial in Worldwide (Idelalisib, Rituximab, Placebo to match idelalisib)

      Completed
      • Chronic Lymphocytic Leukemia
      • Huntsville, Alabama
      • +71 more
      May 1, 2019

      Chronic Lymphocytic Leukemia Trial in Worldwide (Idelalisib, Bendamustine, Rituximab)

      Terminated
      • Chronic Lymphocytic Leukemia
      • Fullerton, California
      • +90 more
      Oct 19, 2018

      Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (Ibrutinib, Chlorambucil)

      Completed
      • Chronic Lymphocytic Leukemia
      • Small Lymphocytic Lymphoma
      • Duarte, California
      • +107 more
      Nov 27, 2017

      Acute Myeloid Leukemia, Myelodysplastic Syndrome, Chronic Lymphocytic Leukemia Trial in United Kingdom, United States (BMN 673)

      Completed
      • Acute Myeloid Leukemia
      • +3 more
      • BMN 673
      • Indianapolis, Indiana
      • +6 more
      Sep 14, 2017

      Chronic Lymphocytic Leukemia Trial in Worldwide (Rituximab, Fludarabine Phosphate, Cyclophosphamide)

      Completed
      • Chronic Lymphocytic Leukemia
      • Birmingham, Alabama
      • +105 more
      Jul 5, 2017